UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018166 |
|---|---|
| Receipt number | R000021037 |
| Scientific Title | Efficacy and safety in SGLT2 inhibitor for diabetes complicated by non-alcoholic fatty liver disease. |
| Date of disclosure of the study information | 2015/07/02 |
| Last modified on | 2022/08/25 16:24:24 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/02 18:27:18 | ||
| 2 | Update | 2015/10/20 20:45:26 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2015/10/20 20:46:56 | Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2015/10/21 17:48:09 | Research ethics review |
|
| 5 | Update | 2015/10/21 17:49:31 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 6 | Update | 2017/05/24 14:32:23 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2018/07/07 11:01:54 | Key exclusion criteria Key exclusion criteria Target sample size |
|
| 8 | Update | 2019/03/04 21:04:51 | Publication of results |
|
| 9 | Update | 2020/01/03 21:28:11 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
| 10 | Update | 2020/07/04 20:26:27 | Date of IRB Last follow-up date |
|
| 11 | Update | 2022/08/25 16:24:24 | Last follow-up date |
